{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T21:55:36Z","timestamp":1712613336744},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jss.2013.06.005","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T21:15:20Z","timestamp":1372540520000},"page":"587-594","source":"Crossref","is-referenced-by-count":3,"title":["Hepatic arterial infusion of temsirolimus inhibits tumor growth of colorectal rat liver metastases even after a growth stimulating procedure like liver resection"],"prefix":"10.1016","volume":"185","author":[{"given":"Jens","family":"Sperling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Ziemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anika","family":"Gittler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Benz-Wei\u00dfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Menger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto","family":"Kollmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2013.06.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clcc.2011.05.005","article-title":"An update on the current and emerging targeted agents in metastatic colorectal cancer","volume":"11","author":"Chu","year":"2012","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.jss.2013.06.005_bib2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/bjs.1800771115","article-title":"Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history","volume":"77","author":"Scheele","year":"1990","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2013.06.005_bib3","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(94)92529-1","article-title":"Factors influencing the natural history of colorectal liver metastases","volume":"343","author":"Stangl","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2013.06.005_bib4","first-page":"1393","article-title":"Hepatocyte growth factor as well as vascular endothelial growth factor gene induction effectively promotes liver regeneration after hepatectomy in Solt-Farber rats","volume":"52","author":"Oe","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jss.2013.06.005_bib5","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1245\/s10434-009-0564-8","article-title":"Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation","volume":"16","author":"Rupertus","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2013.06.005_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1245\/ASO.2006.03.060","article-title":"Profile of plasma angiogenic factors before and after hepatectomy for\u00a0colorectal cancer liver metastases","volume":"13","author":"Yoon","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2013.06.005_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10585-006-9054-6","article-title":"Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells","volume":"24","author":"Rupertus","year":"2007","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.jss.2013.06.005_bib8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","article-title":"Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection\/ablation for colorectal liver metastases","volume":"239","author":"Abdalla","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2013.06.005_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/bjs.1800820144","article-title":"Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor alpha","volume":"82","author":"Slooter","year":"1995","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.jss.2013.06.005_bib10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.surg.2011.12.018","article-title":"The role of liver resection\u00a0for colorectal cancer metastases in an era of multimodality treatment: a systematic review","volume":"151","author":"Quan","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.jss.2013.06.005_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3748\/wjg.v18.i1.25","article-title":"An update on chemotherapy of colorectal liver metastases","volume":"18","author":"Wang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jss.2013.06.005_bib12","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161212800626210","article-title":"Targeting mTOR pathways in human malignancies","volume":"18","author":"Fasolo","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jss.2013.06.005_bib13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI44145","article-title":"Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy","volume":"121","author":"Wander","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jss.2013.06.005_bib14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jss.2013.06.005_bib15","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signaling pathway in human cancer","volume":"13","author":"Populo","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jss.2013.06.005_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1432-2277.2004.00026.x","article-title":"Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer","volume":"18","author":"Guba","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.jss.2013.06.005_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by anti-angiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jss.2013.06.005_bib18","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2004-09-3540","article-title":"Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF","volume":"105","author":"Guba","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jss.2013.06.005_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clcc.2011.12.004","article-title":"Liver-directed Therapies: does it make sense in the current therapeutic strategy for patients with confined liver colorectal metastases?","volume":"11","author":"Seront","year":"2012","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.jss.2013.06.005_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10585-011-9432-6","article-title":"Hepatic arterial infusion of bevacizumab in combination with oxaliplatin reduces tumor growth in a rat model of colorectal liver metastases","volume":"29","author":"Sperling","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.jss.2013.06.005_bib21","first-page":"1761","article-title":"Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy","volume":"60","author":"Drixler","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2013.06.005_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd2062","article-title":"Current development of mTOR inhibitors as anticancer agents","volume":"5","author":"Faivre","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jss.2013.06.005_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12154-008-0003-5","article-title":"Rapamycin and mTOR kinase inhibitors","volume":"1","author":"Ballou","year":"2008","journal-title":"J Chem Biol"},{"key":"10.1016\/j.jss.2013.06.005_bib24","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.4161\/cc.8.22.9946","article-title":"The role of mTORC1 pathway in intestinal tumorigenesis","volume":"8","author":"Fujishita","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jss.2013.06.005_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0039-6060(98)70075-3","article-title":"Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation","volume":"124","author":"Picardo","year":"1998","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.jss.2013.06.005_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jss.2011.09.062","article-title":"Darbepoetin-\u03b1 promotes Neovascularization and cell proliferation in established colorectal liver metastases","volume":"176","author":"Rupertus","year":"2011","journal-title":"J Surg Res"},{"key":"10.1016\/j.jss.2013.06.005_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/SLA.0b013e3181e33915","article-title":"Darbepoetin-\u03b1 enhances hepatectomy-associated stimulation of colorectal liver metastatic growth","volume":"252","author":"Rupertus","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2013.06.005_bib28","first-page":"1527","article-title":"Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor\/medulloblastoma models as single agent and in combination chemotherapy","volume":"61","author":"Geoerger","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2013.06.005_bib29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00280-011-1734-5","article-title":"A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors","volume":"69","author":"Fury","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jss.2013.06.005_bib30","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/JTO.0b013e3182307ede","article-title":"Everolimus in combination with pemetrexed in patients with advanced non-small-cell lung cancer previously treated with chemotherapy: a phase I study using a novel, adaptive Bayesian dose-escalation model","volume":"6","author":"Vansteenkiste","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jss.2013.06.005_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2011.08940.x","article-title":"Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)","volume":"156","author":"Amadori","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jss.2013.06.005_bib32","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1634\/theoncologist.2011-0078","article-title":"A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer","volume":"16","author":"Altomare","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.jss.2013.06.005_bib33","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1158\/1078-0432.CCR-10-2979","article-title":"Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer","volume":"17","author":"Naing","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2013.06.005_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejca.2011.09.021","article-title":"Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma, and rhabdomyosarcoma","volume":"48","author":"Geoerger","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2013.06.005_bib35","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1200\/JCO.2010.33.4649","article-title":"Phase I study of temsirolimus in pediatric patients with recurrent\/refractory solid tumors","volume":"29","author":"Spunt","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2013.06.005_bib36","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ejca.2011.02.017","article-title":"A phase I study of sirolimus and bevacizumab in patients with advanced malignancies","volume":"47","author":"Cohen","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2013.06.005_bib37","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1200\/JCO.2008.21.3033","article-title":"Randomized phase II study comparing two schedules of everolimus in patients with recurrent\/metastatic breast cancer: NCIC Clinical Trials Group IND.163","volume":"27","author":"Ellard","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2013.06.005_bib38","first-page":"CD007823","article-title":"Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer","author":"Mocellin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jss.2013.06.005_bib39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1634\/theoncologist.8-6-553","article-title":"An update on hepatic arterial infusion chemotherapy for colorectal cancer","volume":"8","author":"Cohen","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.jss.2013.06.005_bib40","first-page":"969","article-title":"The blood supply of neoplasms in the liver","volume":"30","author":"Breedis","year":"1954","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jss.2013.06.005_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ar.1091670307","article-title":"The fine structure of the terminal branches of the hepatic arterial system of the rat","volume":"167","author":"Burkel","year":"1970","journal-title":"Anat Rec"},{"key":"10.1016\/j.jss.2013.06.005_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/jsre.2000.5978","article-title":"Microvasculature of small liver metastases in rats","volume":"94","author":"Gonda","year":"2000","journal-title":"J Surg Res"},{"key":"10.1016\/j.jss.2013.06.005_bib43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s002800050827","article-title":"Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in\u00a0vivo 19F NMR study","volume":"42","author":"Okuno","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jss.2013.06.005_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.mn.7300054","article-title":"Vascular endothelial growth factor and microvascular permeability","volume":"6","author":"Bates","year":"1999","journal-title":"Microcirculation"},{"key":"10.1016\/j.jss.2013.06.005_bib45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1549-8719.2009.00012.x","article-title":"Rapamycin inhibits VEGF-induced microvascular hyperpermeability in\u00a0vivo","volume":"17","author":"Kim","year":"2010","journal-title":"Microcirculation"},{"key":"10.1016\/j.jss.2013.06.005_bib46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jacc.2005.01.062","article-title":"Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction","volume":"46","author":"Togni","year":"2005","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480413005945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480413005945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T22:52:20Z","timestamp":1539557540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480413005945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0022480413005945"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2013.06.005","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}